Benzinga | Dec 7, 2021 07:33AM EST

Cowen & Co. Initiates Coverage On Vicarious Surgical with Outperform Rating, Announces Price Target of $15

Cowen & Co. analyst Joshua Jennings initiates coverage on Vicarious Surgical (NYSE:RBOT) with a Outperform rating and announces Price Target of $15.